KAYLA ROBERTS: Open Payments
NPI 1619502036 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,495 in 63 payments from 11 companies in 2025. Trend: 2023 $487 · 2024 $962 · 2025 $1,495
Food & beverage: $1,495
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 10 | $310 |
| Corium, LLC | 9 | $244 |
| Axsome Therapeutics, Inc. | 3 | $213 |
| Supernus Pharmaceuticals, Inc. | 25 | $210 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $154 |
| Otsuka America Pharmaceutical, Inc. | 1 | $113 |
| Janssen Pharmaceuticals, Inc | 5 | $95 |
| Lundbeck LLC | 2 | $55 |
| ABBVIE INC. | 2 | $42 |
| Collegium Pharmaceutical, Inc. | 2 | $41 |
Products named: FANAPT, Azstarys, Auvelity, Qelbree, REXULTI, CAPLYTA, SPRAVATO, VRAYLAR.
Industry payments across FL — which companies pay providers there.
